Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEUPROLIDE vs LEVOBUNOLOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEUPROLIDE vs LEVOBUNOLOL: Safety Overview

Metric LEUPROLIDE LEVOBUNOLOL
Total FAERS Reports 70,893 144
Deaths Reported 11,858 2
Death Rate 16.7% 1.4%
Hospitalizations 10,499 7
Average Patient Age 67.5 yrs 76.5 yrs
% Female Patients 14.1% 65.8%
FDA Approval Date Apr 14, 2023 Aug 3, 2000
Manufacturer TOLMAR Inc. Bausch & Lomb Incorporated
Route SUBCUTANEOUS OPHTHALMIC
Marketing Status Discontinued Prescription